Evaluation of Immunogenicity of Type B Toxoid and Inactivated FMD (O) Virus with Adjuvant (ISA70-MF59).

Arch Razi Inst

Department of Anaerobic Vaccine Research and Production, Specialized Clostridia Research Laboratory, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.

Published: June 2023

Foot and mouth disease (FMD) and enterotoxemia are important diseases of hoofed animals. Vaccination against livestock pathogens, especially these two diseases, plays a key role in the prevention and control of these diseases. The use of combined vaccines with the aim of creating a better immune response and producing cheaper vaccines is a great contribution to Vaccine industry. This research aimed to compare the immunogenicity of FMD (O) and type B toxoid along with adjuvant (MF59) and Montanide (ISA70) to create the best immunogenicity. To investigate the immune responses of vaccines, it was injected into an animal model, and the antibody titer was measured by enzyme-linked immunosorbent assay (ELISA) test and VN antibody titer. The results showed that the formulation with MF59 adjuvant brought more stable immunogenicity against FMD and type B, and the length of the immunogenicity period also increased significantly. Therefore, the combined vaccine ( + FMD) could play a major role invaccine industry as an alternative vaccine against and FMD in livestock.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657933PMC
http://dx.doi.org/10.22092/ARI.2022.360215.2565DOI Listing

Publication Analysis

Top Keywords

type toxoid
8
immunogenicity fmd
8
fmd type
8
antibody titer
8
vaccine fmd
8
fmd
6
evaluation immunogenicity
4
immunogenicity type
4
toxoid inactivated
4
inactivated fmd
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!